Fernandez, Eve F.
HRN: 21-73-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2022
CEFUROXIME 500MG (TAB)
08/08/2022
08/13/2022
PO
500mg
BID
S/p Pelvic Lap
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes